Overview
Injective vs AB is one of the most watched crypto matchups. Beyond headline prices, this comparison blends market structure, technical readings and probabilistic context without promising outcomes.
Quick winners
Full comparison
| Metric | INJ | AB |
|---|---|---|
| Price | $4.99 | $1,861.70 |
| Market Cap | $490.41M | $96.56M |
| FDV | — | — |
| Volume 24h | $2.65M | $350,995.00 |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 261.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.97% | +3.64% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | AB |
|---|---|---|
| 1H | — | — |
| 24H | +1.03% | -0.20% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | AB |
|---|---|---|
| RSI | 49.29 | 49.02 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 67.35 |
| ADX | 12.19 | 21.33 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.07 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 65.00 |
| Signal | neutral | neutral |
Automatic technical analysis
When RSI and trend disagree across Injective and AB, expect choppy relative performance until one side reclaims a clear structure.
Fundamentals
| Metric | INJ | AB |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
AB
Pros and cons
Pros of Injective
- INJ often anchors narratives that attract sustained media and analyst coverage.
- Market-cap scale on Injective may dampen some idiosyncratic shocks versus smaller peers.
- Injective has an established coin page footprint on PEPS for continuous monitoring.
Cons of Injective
- Indicator stacks on Injective may stay stretched longer than expected in strong trends.
- Large-cap status for Injective can mean slower percentage upside versus high-beta alternatives.
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
Pros of AB
- If technical momentum aligns, AB may outperform on medium-term windows.
- AB can offer higher relative beta when market attention rotates toward its niche.
- Diversifying versus Injective with AB can change portfolio factor exposure.
- PEPS tracking for AB still includes AI score and level context for monitoring.
Cons of AB
- Relative underperformance versus Injective can persist through entire market regimes.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Weaker market-cap standing may leave AB more exposed to liquidity droughts.
Which looks stronger right now?
The “stronger” label here is descriptive, not predictive. Injective and AB can alternate leadership as macro liquidity and narrative rotate.
AI summary
PEPS synthesizes module output into a readable pair brief. Headline stats put Injective at $4.99 and AB at $1,861.70. Relative performance over 24h (Injective) is a short window. Pair it with 30d/1y rows before inferring regime change. Return to related comparisons and individual coin intelligence pages to validate whether the relative story still holds after fresh prints.
FAQ
Which is better, Injective or AB?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or AB?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and AB.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.